Please login to the form below

Not currently logged in
Email:
Password:

business models

This page shows the latest business models news and features for those working in and with pharma, biotech and healthcare.

Edging Evolution

Edging Evolution

In my research, I’m interested in how it leads to new competitive strategies, organisational behaviours and business models in the life sciences industry. ... Evolution of your business model doesn’t have to be synonymous with slow change.

Latest news

  • It's Complicated It's Complicated

    My research reveals the mechanism of how business models evolve or become extinct and my advisory work with companies involves applying that research to their particular business context. ... Stopping commercial executives taking complicated ideas from

  • Quick Change Quick Change

    Professor Brian D Smith is an authority on the pharmaceutical industry and works at SDA Bocconi University and Hertfordshire Business School. ... And the same idea-transfer benefits arise from using evolutionary theory to understand how business models

  • Gottlieb admonishes industry for clinical trial failings Gottlieb admonishes industry for clinical trial failings

    The industry seems wedded to “legacy business models that discourage collaboration and data sharing,” he asserts, warning that unless changes are made to streamline the clinical trials process “ important therapeutic opportunities ... It covers

  • Gene Genie Gene Genie

    Professor Brian D Smith is an authority on the pharmaceutical industry and works at SDA Bocconi University and Hertfordshire Business School. ... That’s where the money lies, so that’s where evolution will lead the business models of cell and gene

  • UK biotech booms in 2018, despite Brexit worries UK biotech booms in 2018, despite Brexit worries

    Bates said that other trends included a diversification in the UK life science industry, for example with the emergence of new business models in areas such as artificial intelligence, as well

More from news
Approximately 13 fully matching, plus 115 partially matching documents found.

Latest Intelligence

  • Assessing the risks in annuity pricing models Assessing the risks in annuity pricing models

    Manufacturers will need to restructure traditional business and revenue forecasting models or develop entirely new models based on reimbursement timelines. ... of long-term patient monitoring, the need to make reimbursement decisions based on very

  • Creating value from value-based healthcare Creating value from value-based healthcare

    Why pharma companies need to implement novel business models and more. ... The companies that are able to identify the systems and stakeholders willing to pay for both outcomes and savings on total costs will be able to implement novel business models,.

  • Changing direction: adapting to a rapidly-evolving environment Changing direction: adapting to a rapidly-evolving environment

    impacted both profitability and business models alike. ... The picture continues to change, with new entrants, emergent disrupters and a diverse range of business models providing a perfect balance of opportunities and threats for the industry.

  • Streamlining clinical trials – why better data use is key Streamlining clinical trials – why better data use is key

    Big data, blockchain technology and artificial intelligence have given industry the chance to streamline drug trials, say experts, who agree with recent FDA calls for more efficient clinical research models. ... Gottlieb blamed “legacy business models

  • It’s not the end of the world, is it? It’s not the end of the world, is it?

    Strategic planners in pharma rarely consider the possibility of a business apocalypse and, to a degree, they are correct not to do so. ... But some ‘black swans’ also fall into the category of HILF – high-impact, low-frequency events that would, if

More from intelligence
Approximately 6 fully matching, plus 32 partially matching documents found.

Latest appointments

  • Huntingdon Life Sciences appoints Joseph Bedford Huntingdon Life Sciences appoints Joseph Bedford

    The job spans the company's contract research services (CRS) and research models services (RMS) business units, with responsibility for global marketing, business intelligence, strategic planning and some aspects of corporate

  • Lilly names head of corporate business development Lilly names head of corporate business development

    Promotion for Darren Carroll. Lilly has promoted Darren Carroll to senior VP of corporate business development. ... During his career at the company, Carroll has helped lead and create new business models for the firm including e-Lilly, InnoCentive,

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Digital applications are transforming the market access landscape Digital applications are transforming the market access landscape

    Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy. ... Organisations can leverage this technology to implement a

  • What Pharma can learn from B2B digital trends

    The impact of digital has fundamentally changed business models across UK industries over the last 10 years. ... Today, they represent 35% of all workers. And their expectations of business communication is shaped from their B2C experience.

  • Practical Patient Centricity

    Our experience with a number of pharmaceutical companies highlights a range of approaches to this challenge, and in this paper we explore ways in which some are changing their business models ... These may be outside the current scope of the company’s

  • Digital trends in B2B sales - how far behind is Pharma?

    The impact of digital has fundamentally changed business models across UK industries over the last 10, or so, years. ... ATKearney states that “despite being an information-intensive industry, healthcare’s business model has remained strangely

  • Fresh thinking for the Porterhouse Medical Group

    Pharma is at a crossroads as companies look to evolve their business models.

More from PMHub
Approximately 1 fully matching, plus 14 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Using human insights to push healthcare communications forward
This blog highlights the value of human perspectives, showing how insights can propel healthcare communications forward to ultimately improve lives...
RWE Blog 4: The place of real-world evidence in the market access strategy
The fourth and final blog in our latest series focuses on market access strategy. This follows our evaluation of the role of real-world data (RWD) and real-world evidence (RWE) in...
RWE Blog 3: Is real-world evidence the holy grail
We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...

Infographics